585 related articles for article (PubMed ID: 18480196)
21. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
Ngaage DL; Bland JM
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1375-83. PubMed ID: 20117944
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
Brown JR; Birkmeyer NJ; O'Connor GT
Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
24. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
25. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
Martin K; Wiesner G; Breuer T; Lange R; Tassani P
Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
[TBL] [Abstract][Full Text] [Related]
26. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
27. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
29. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
[TBL] [Abstract][Full Text] [Related]
30. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
Koster A; Schirmer U
Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
[TBL] [Abstract][Full Text] [Related]
31. Current antifibrinolytic therapy for coronary artery revascularization.
Trudell J; McMurdy N
AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817
[TBL] [Abstract][Full Text] [Related]
32. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
Carless PA; Moxey AJ; Stokes BJ; Henry DA
BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
[TBL] [Abstract][Full Text] [Related]
33. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
34. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
Martin K; Knorr J; Breuer T; Gertler R; Macguill M; Lange R; Tassani P; Wiesner G
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):20-5. PubMed ID: 21272777
[TBL] [Abstract][Full Text] [Related]
35. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
Riddell RE; Buth KJ; Sullivan JA
Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
Nicolau-Raducu R; Subramaniam K; Marquez J; Wells C; Hilmi I; Sullivan E
J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):73-9. PubMed ID: 19717314
[TBL] [Abstract][Full Text] [Related]
37. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
39. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
40. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
